Skip to content
Medical Health Aged Care, Science

Researchers identify neurons in the brain that control nasofacial muscles during breathing

The Florey 2 mins read
Whilst most of us consider breathing a relatively simple process, it actually requires complex coordination of many muscles to enable airflow into and out of the lungs and to control airflow to allow us to talk, eat, and drink.

Breathing also influences other related brain functions, such as emotional state, sense of smell, blood pressure, and heart rate.

Breathing is generated in a brain region called Pre-Bötzinger complex (preBötC), which is composed of many subgroups of neurons that are breathing and non-breathing related.

Up to now, due to technical limitations, it was almost impossible to specifically silence a subgroup of neurons that control a non-breathing function without adversely affecting breathing.In a new study, on pre-clinical models, published in eLife , researchers at The Florey and the University of Melbourne have developed a new methodology to overcome this issue and have now shown that a subgroup of neurons in the preBötC control the nasofacial muscles.

This was the first step to enable the understanding of how breathing is coordinated with or regulates non-breathing functions.

Co-authors Dr Stuart McDougall from The Florey and Dr Mariana Melo from the University of Melbourne said: “Our research sets a technical foundation for exploring the influence of specific subgroups of preBötC neurons on non-breathing function.”

“Our next step will be to understand the influence of the preBötC on respiratory modulation of other linked physiological functions. For example, we aim to manipulate blood pressure, without altering the control of breathing, to affect the development of high blood pressure.

“More broadly, most brain regions contain complex, functionally heterogeneous groups of neurons, and we validate another method that could be applied to specifically examining subgroups of neurons.”

“As breathing also modulates other functions such as emotional state, blood pressure, and heart rate, it might be feasible to hijack respiratory modulation of these functions, such as blood pressure and heart rate in hypertension and heart failure into the future.


Contact details:

Kathryn Powley

Media and Communications Manager

The Florey

0456 666 271 | [email protected]

More from this category

  • General News, Medical Health Aged Care
  • 12/03/2026
  • 14:07
Parliament of Australia

Public hearing concerning the National Redress Scheme

TheJoint Standing Committee on Implementation of the National Redress Schemewill hold a public hearing in Canberra on Friday, 13 March 2026, for itsinquiry into the continuing operation of the Scheme. Committee Chair, Ms Jodie Belyea MP, said the Committee is grateful for the contributions made in support of the inquiry to date. ‘The National Redress Scheme plays a central role in Australia’s response to institutional child sexual abuse. It is an important program for a significant number of people. The Committee has received a substantial number of submissions in support of our current inquiry, and public hearings over the coming…

  • Energy, Medical Health Aged Care
  • 12/03/2026
  • 12:11
Sweltering Cities

The cost of keeping cool is making Australians sick: New report reveals millions forced to ration cooling during record heat

12 March 2026 Sweltering Cities has today released the findings of its 2026 Summer Survey, exposing a national health crisis driven by the rising cost of keeping cool. With data from more than 2,600 respondents across 766 postcodes, the report proves that for many Australians the high cost of staying cool is having serious physical and mental health impacts. The 2025/26 summer saw 68% of all respondents report feeling unwell due to heat. However, the survey reveals that this burden is falling most heavily on those already struggling with the cost of living. For renters and people with disabilities, the…

  • Medical Health Aged Care
  • 12/03/2026
  • 10:01
Monash University

Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and transport function, backed by an up to $22.4 million AUD Award from the Advanced Research Projects Agency for Health (ARPA-H). The researchers join ARPA-H’s GLIDE (Groundbreaking Lymphatic Interventions and Drug Exploration) program to transform how both primary lymphatic diseases and common chronic diseases are treated by developing innovative therapeutics that alleviate, repair or regenerate a dysfunctional lymphatic vascular system. Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, said the work…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.